RC 591Alternative Names: PNS; Polymeric nasal spray - Johnson & Johnson; RC-591
Latest Information Update: 25 Jun 2015
At a glance
- Originator Johnson & Johnson; McNeil-PPC
- Class Antivirals
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Common cold
Most Recent Events
- 08 May 2012 McNeil completes a phase II trial in Common cold in United Kingdom (NCT01488604)
- 13 Jan 2012 Phase-II clinical trials in Common cold in United Kingdom (Intranasal)